Elanco Animal Health Incorporated Common Stock
Here’s whether Elanco Animal Health Incorporated Common Stock (ELAN) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Neutral.
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); RSI 64 — healthy momentum range; strong 1-year return of +70.6%. Concerns: 50-day MA is falling (-0.23% over 10 days); declining volume on rally — weak conviction (0.79x 30d avg). Currently 12.8% off its 52-week high. Score: +3/7.
ELAN is in a confirmed uptrend, trading above both its 50-day ($22.90) and 200-day ($22.50) moving averages. An RSI of 64.3 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +70.6% compares to +22.9% for SPY (beat the market by 47.7%).